Hassan Ali Ahmed, Flood Michelle, Kirke Ciara, Mattsson Molly, Walsh Mary E, Wallace Emma, Corrigan Derek, Fahey Tom, Boland Fiona, Moriarty Frank
School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences, Dublin, Leinster, Ireland.
National Medication Safety Programme, HSE National Quality and Patient Safety Directorate, Dublin, Dublin, Ireland.
HRB Open Res. 2025 May 27;8:36. doi: 10.12688/hrbopenres.14080.2. eCollection 2025.
The Health Service Executive (HSE) in Ireland releases monthly reports on prescription dispensing claims and payments relating to community drug schemes. This paper describes the implementation of an R-based Shiny application that facilitates interactive visualisation and analysis of trends in medication prescribing and improves the data's practical value, and presents use cases focused on drug utilisation and medication policy questions.
Using Primary Care Reimbursement Service (PCRS) data provided by the HSE relating to the means-tested General Medical Services (GMS) scheme covering approximately one-third of the population, an R-based Shiny application was developed. This application uses monthly prescribing and cost data from 2016 up to the most recent data available (currently October 2024) relating to the 100 most commonly prescribed medications (by frequency and cost) and all therapeutic groups. The application leverages a range of R packages to enable users to select medications, therapeutic groups, and physiological systems to explore and compare prescribing and cost trends over time.
The RxTrends Shiny application effectively integrates PCRS data, providing multiple functionalities that allow for visualisation of dispensing trends of multiple medications, therapeutic groups and physiological systems. Graphs are available across multiple prescribing frequency and cost metrics and can be restricted to a selected time period. The 'compare' function visualises the proportion of prescribing/cost a selected medication or therapeutic group accounts for within a therapeutic group or physiological system. Use cases relating to Ireland's Preferred Drug Initiative, availability of generic products and reference pricing, and seasonality of drug utilisation are presented.
The application provides an interactive interface for stakeholders to visualise and monitor prescribing patterns using data from monthly PCRS reports. The application increases access to and usability of PCRS data for various audiences for whom it may be of interest, including researchers, healthcare professionals, policymakers and the general public.
爱尔兰卫生服务执行局(HSE)每月发布有关社区药物计划的处方配药索赔和支付情况的报告。本文描述了一个基于R的Shiny应用程序的实施情况,该应用程序有助于对药物处方趋势进行交互式可视化和分析,并提高数据的实用价值,并展示了专注于药物利用和药物政策问题的用例。
利用HSE提供的与经过经济状况调查的一般医疗服务(GMS)计划相关的初级保健报销服务(PCRS)数据,该计划覆盖约三分之一的人口,开发了一个基于R的Shiny应用程序。该应用程序使用2016年至最新可用数据(目前为2024年10月)的月度处方和成本数据,这些数据涉及100种最常用的药物(按频率和成本)以及所有治疗组。该应用程序利用一系列R包,使用户能够选择药物、治疗组和生理系统,以探索和比较随时间变化的处方和成本趋势。
RxTrends Shiny应用程序有效地整合了PCRS数据,提供了多种功能,可对多种药物、治疗组和生理系统的配药趋势进行可视化。可通过多个处方频率和成本指标获取图表,并可限制在选定的时间段内。“比较”功能可直观显示所选药物或治疗组在治疗组或生理系统中所占的处方/成本比例。展示了与爱尔兰首选药物倡议、仿制药可用性和参考定价以及药物利用季节性相关的用例。
该应用程序为利益相关者提供了一个交互式界面,以便使用PCRS月度报告中的数据来可视化和监测处方模式。该应用程序增加了PCRS数据对各种感兴趣受众的可及性和可用性,这些受众包括研究人员、医疗保健专业人员、政策制定者和公众。